The 2-year timeline is an approximation, but if RVNC had decided to go the sBLA route for the 50U vial, the sBLA submission would’ve had to wait until the FDA completed its review of the original BLA.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”